## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Structural basis of thrombin–protease-activated receptor interactions
✍ Scribed by Prafull S. Gandhi; Zhiwei Chen; Eric Appelbaum; Fatima Zapata; Enrico Di Cera
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 418 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1521-6543
- DOI
- 10.1002/iub.461
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Aggregation of platelets is an essential step in the formation of a stable blood clot during vascular injury. The trypsin‐like protease thrombin acts as the dominant agonist of platelet activation on engagement of protease‐activated receptors (PARs). Important details on the molecular aspects of thrombin–PAR interactions have been revealed recently by structural biology. In the case of human platelets, PAR1 engages thrombin via an extended surface of recognition encompassing the active site and exosite I. In the case of murine platelets, PAR4 binds to the active site in a conformation that leaves exosite I free for interaction with cofactors like PAR3. Human PAR4 mimics the murine receptor binding mechanism for residues upstream of the scissile bond. This information is consistent with existing functional data and provides a solid background for future structural and mutagenesis studies of PAR interaction with thrombin and related proteases. © 2011 IUBMB IUBMB Life, 63(6): 375–382, 2011
📜 SIMILAR VOLUMES
This paper describes the development of galactosidase protease-activated receptor (GPAR) as a recombinant protein obtained by fusion of -galactosidase, the extracellular domains of protease-activated receptors (PARs), and a biotin acceptor domain. Used as an immobilized substrate, this protein allo
## Abstract Regulation of thrombin activity may be required during skeletal muscle differentiation since the thrombin tissue inhibitor protease nexin‐1 appears at the myotube stage before being localized at the neuromuscular synapse. Here, we have used a model of rat fetal myotube primary cultures